Literature DB >> 26028498

The inducible E3 ubiquitin ligases SIAH1 and SIAH2 perform critical roles in breast and prostate cancers.

Shirley K Knauer1, Nisintha Mahendrarajah2, Wynand P Roos2, Oliver H Krämer3.   

Abstract

The ubiquitin-dependent proteasomal degradation of proteins controls signaling and cellular survival. An increasing body of evidence suggests that the E3 ubiquitin ligases SIAH1 and SIAH2 are able to dictate the growth, development, and chemo-/radiosensitivity of breast and prostate cancer cells. Here we review the current knowledge on the impact of SIAHs on breast and prostate tumorigenesis. Furthermore, we summarize how stress, hormones, and cytokines regulate SIAH1 and SIAH2 in transformed mammalian cells.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokine; Estrogen; SIAH1; SIAH2; Sex hormone

Mesh:

Substances:

Year:  2015        PMID: 26028498     DOI: 10.1016/j.cytogfr.2015.04.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  14 in total

1.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

2.  Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer.

Authors:  Duy T Nguyen; Wei Yang; Kiran Mahajan; Arun Renganathan; Cody Weimholt; Duminduni H Angappulige; Thanh Nguyen; Robert W Sprung; Gerald L Andriole; Eric H Kim; Nupam P Mahajan
Journal:  Clin Cancer Res       Date:  2022-09-15       Impact factor: 13.801

3.  "The ubiquitin ligase SIAH2 is a female-specific regulator of circadian rhythms and metabolism".

Authors:  Tsedey Mekbib; Ting-Chung Suen; Aisha Rollins-Hairston; Kiandra Smith; Ariel Armstrong; Cloe Gray; Sharon Owino; Kenkichi Baba; Julie E Baggs; J Christopher Ehlen; Gianluca Tosini; Jason P DeBruyne
Journal:  PLoS Genet       Date:  2022-07-05       Impact factor: 6.020

4.  Histone deacetylase inhibitors induce proteolysis of activated CDC42-associated kinase-1 in leukemic cells.

Authors:  Nisintha Mahendrarajah; Ramin Paulus; Oliver H Krämer
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

Review 5.  DNA damage and the balance between survival and death in cancer biology.

Authors:  Wynand P Roos; Adam D Thomas; Bernd Kaina
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

6.  miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.

Authors:  Ya-Ping Ye; Ping Wu; Chun-Cai Gu; Dan-Ling Deng; Hong-Li Jiao; Ting-Ting Li; Shu-Yang Wang; Yong-Xia Wang; Zhi-Yuan Xiao; Wen-Ting Wei; Yan-Ru Chen; Jun-Feng Qiu; Run-Wei Yang; Jie Lin; Li Liang; Wen-Ting Liao; Yan-Qing Ding
Journal:  Oncotarget       Date:  2016-09-20

7.  Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid Leukemia Chemo-Resistance in Hypoxic Microenvironment.

Authors:  Jixian Huang; Ziyuan Lu; Yajuan Xiao; Bolin He; Chengyun Pan; Xuan Zhou; Na Xu; Xiaoli Liu
Journal:  Med Sci Monit       Date:  2018-02-05

8.  HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1.

Authors:  Mandy Beyer; Annette Romanski; Al-Hassan M Mustafa; Miriam Pons; Iris Büchler; Anja Vogel; Andrea Pautz; Andreas Sellmer; Günter Schneider; Gesine Bug; Oliver H Krämer
Journal:  Cancers (Basel)       Date:  2019-09-26       Impact factor: 6.639

9.  Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor Activity.

Authors:  Hao Zheng; Wen-Juan Zheng; Zhen-Guang Wang; Yuan-Ping Tao; Zhi-Ping Huang; Le Yang; Liu Ouyang; Zhi-Qing Duan; Yi-Nuo Zhang; Bo-Ning Chen; Dai-Min Xiang; Gang Jin; Lu Fang; Fan Zhou; Bo Liang
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

10.  Downregulation of Siah1 promotes colorectal cancer cell proliferation and migration by regulating AKT and YAP ubiquitylation and proteasome degradation.

Authors:  Zhiyuan Xiao; Zhigang Wei; Danling Deng; Zhe Zheng; Yali Zhao; Shenglu Jiang; Dan Zhang; Ling-Jie Zhang; Mingmei Fan; Siqi Chen; ShuYang Wang; Yanqing Ding; Yaping Ye; Hongli Jiao
Journal:  Cancer Cell Int       Date:  2020-02-13       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.